In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List

Targeted Intracellular Delivery Summit

Mar 07, 2023 - 09:30 AM - Mar 09, 03:30 PM
Hanson Wade
Hilton Boston Back Bay
40, Dalton St

ZIP: 02115
Phone: +16174554188

Ticket Price: USD 2999.00 - USD 4348.00

It has long been understood that the ability to deliver therapeutic cargos to cytosolic sites of action in target tissue could unlock access to previously undruggable targets, whilst enabling the development of safer and efficacious drugs.

Now, advances in nanomedicine technology, the LNP-enabled mRNA vaccine and modern medicine's shift towards a more personalized model are fuelling excitement amongst drug developers as they position their pipelines towards utilizing novel delivery systems which effectively engage previously elusive intracellular targets.

With mounting investments, industry collaborations and interest in leveraging next-generation nano vehicles, from LNP's, liposomes, EV's, polymeric nanoparticles (and beyond!), new avenues have been opened for optimizing the therapeutic index of novel pipelines, from antisense oligonucleotides, siRNA, mRNA and DNA delivery to peptide protein drugs.

It's timely for the Targeted Intracellular Delivery Summit to arrive as your only industry dedicated forum, focussed on accelerating the mechanistic understanding and potential of much-needed intracellularly delivery technologies through exploiting an advanced understanding of membrane biology and biological barriers.

Uniting the leading minds of large pharma, biotech and academia, unite with Formulation, Chemistry, Delivery and Biology as industry showcases the pioneering discoveries, critical findings and novel approaches fast-tracking  promising candidates towards the clinic.

Group discounts and early booking rates are available. Please visit the website for full pricing information.

Tickets: https://go.evvnt.com/1443409-2?pid=1052
Brochure: https://go.evvnt.com/1443409-3?pid=1052

Drug Developer - Conference + 1 Workshop: USD 3648.00,
Drug Developer - Conference Only: USD 2999.00,
Solution and Service Provider - Conference + 1 Workshop: USD 4348.00,
Solution and Service Provider - Conference Only: USD 3599.00

Speakers: Allen Horhota, Senior Director, Head of Delivery, Orna Therapeutics, Avidor Shulman, Chief Technology Officer, Biond Biologics, Ben Spangler, Senior Scientist, BioMarin Pharmaceutical, Christopher Locher, Chief Executive Officer, Versatope, David Guay, Vice President, Innovation and Technology, Feldan Therapeutics, De-Min Zhu, President and Chief Executive Officer, Cureport, Ernst Wagner, Professor, Ludwig- Maximilians- Universität München, Fionnuala Lane, Program Director, Targeted Drug Delivery Series, Gibeom Kim, Laboratory Director, ShiftBio, Guy Hermans, Chief Executive Officer, Sapreme Technologies, Heinrich Haas, Vice President, RNA Formulation and Drug Delivery, BioNTech, James Ferguson Chief Medical Officer, Matinas BioPharma, Kalina Paunovska, Co-Founder, Nava Therapeutics, Manmohan Singh, Chief Technology Officer, Beam Therapeutics, Michael Munson, Senior Research Scientist, AstraZeneca, Niren Murthy, Professor, Department of Bioengineering, University of California, Berkeley, Qi-Ying Hu, Vice President, Head of Formulation and Delivery, Omega Therapeutics, Rui Zhang, Associate Director, LNP Formulation, Tessera Therapeutics, Sean Bedingfield, Research Engineer, Lilly Genetic Medicine, Eli Lilly and Company, Shalom Goldberg, Senior Principal Scientist, Johnson and Johnson

Event Categories
Keywords: conference


Events Calendar

26 27 28 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 1

Event Location


VIP Life Time Subscription to our Newsletters!